Clin2
NCT07661446Possibly a fitNot yet recruiting

Cannabis for opioid withdrawal

Opioid Use DisordersCannabis Use

Part of Mental health clinical trials.

This study tests whether cannabis can help people with moderate to severe opioid use disorder manage withdrawal symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You have been diagnosed with moderate to severe opioid use disorder.
  • You experience withdrawal symptoms when you stop using opioids.
  • You are not a person who does not use opioids.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07668635Not yet recruiting· Phase 1
Cannabis effects on opioid use in withdrawal

This study tests whether cannabis can help people with opioid withdrawal and reduce opioid use. You will stay in a research center and receive cannabis in a controlled setting while researchers monitor your symptoms.

Lexington, Kentucky
NCT05729932Recruiting· Phase 1
Cannabis and opioid use disorder study

This Phase 1 trial studies cannabis in people with opioid use disorder. The goal is to better understand how it may affect opioid use disorder, while monitoring safety.

Lexington, Kentucky
NCT07434895Recruiting· Early Phase 1
Can CBD Change How You Use Cannabis?

This study looks at how taking CBD (a cannabis compound that doesn't get you high) affects your cannabis use. It is for healthy adults who use cannabis for recreational reasons, not for medical treatment.

Lexington, Kentucky
NCT05985850Recruiting· Phase 2
Can cannabis help with opioid addiction treatment?

This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.

Vancouver, British Columbia
NCT07148206Not yet recruiting· Phase 3
Cannabis medicines for opioid withdrawal with buprenorphine start

This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.

The Bronx, New York
NCT06206252Recruiting
Can Medical Cannabis Help Reduce Opioid Use?

This study tests whether medical cannabis can help people who take opioids for long-term pain reduce their opioid use. Participants will either use medical cannabis or continue without it for 3 months.

Philadelphia, Pennsylvania

Hear when a new Cannabis Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.